showing 1496 abstracts from year 2012
filter abstracts
Details |
title |
year |
Details |
“It Gets Me Down Every Single Day”: Are Men with Rheumatoid Art... |
2012 |
Details |
1,25(OH)2D3 Modulates the Migration Pattern of Th17 C... |
2012 |
Details |
10-Year Trends in the Use of Disease Modifying Anti-Rheumatic Drugs (DMARDs... |
2012 |
Details |
12- and 24-Week Patient-Reported Outcomes From a Phase 2b Dose-Ranging Stud... |
2012 |
Details |
14-3-3 Eta Is a Modifiable Serum Biomarker That Marks Adalimumab Response i... |
2012 |
Details |
14-3-3 Eta Is a Novel Citrullination Target in Rheumatoid Arthritis That En... |
2012 |
Details |
24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an... |
2012 |
Details |
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Eff... |
2012 |
Details |
A Brazilian Multicenter Study of 71 Children and Adolescents with Takayasuâ... |
2012 |
Details |
A Brazilian Portuguese Validation of the Revised Fibromyalgia Impact Questi... |
2012 |
Details |
A British Survey of Time to Presentation and Treatment of Rheumatoid Arthri... |
2012 |
Details |
A Clinical Analysis of Adult Patients with Autoimmune- and Infection-Associ... |
2012 |
Details |
A Comparison of Systemic Lupus Erythematosus (SLE) Patients Achieving Prolo... |
2012 |
Details |
A Comparison of the Nociceptive Flexion Reflex, Pressure Algometry and Summ... |
2012 |
Details |
A Comparison of Three Methods of Measuring Intermalleolar Distance in Patie... |
2012 |
Details |
A Comparison of Unilateral and Bilateral Hip BMD... |
2012 |
Details |
A Competence-Based Model for Teaching Rheumatology in Undergraduate Medical... |
2012 |
Details |
A Comprehensive Study of Novel Serum Markers of ILD Associated with Inflamm... |
2012 |
Details |
A Double-Blind Placebo-Controlled Crossover Trial of the Alpha-2C
2012 |
|
Details |
A Functional Growth Hormone Receptor Polymorphism, Exon 3 Deleted Ghr, Is A... |
2012 |
1 2 3 4 5 6 7 8 ...75 Next